Institutional Ownership
Tempest Therapeutics Inc
CUSIP 87978U108COMTPSTQ1 2026
13D / 13G Filings
20
Schedule 13D/13G on record
Beneficial Filers
7
Distinct reporting persons
Largest Stake
14.4%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
20 filings · latest Aug 13, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Aug 13, 2025 | Versant Venture Capital Vi, L.P. | 13D/A | 3.7% | — | SEC |
| 2 | Feb 11, 2025 | Versant Venture Capital Vi, L.P. | 13D/A | 4.8% | — | SEC |
| 3 | Aug 12, 2024 | Versant Venture Capital Vi, L.P. | 13D/A | 0.8% | 209.9K | SEC |
| 4 | May 13, 2024 | Versant Venture Capital Vi, L.P. | 13D/A | 4.5% | 997.9K | SEC |
| 5 | Feb 14, 2024 | Rock Springs Capital Management LP | 13G/A | — | — | SEC |
| 6 | Feb 14, 2024 | Ecor1 Capital, LLC | 13G/A | — | — | SEC |
| 7 | Feb 9, 2024 | Fmr LLC | 13G/A | 2.2% | — | SEC |
| 8 | Feb 8, 2024 | Versant Venture Capital Vi, L.P. | 13D/A | 5.2% | 997.9K | SEC |
| 9 | Nov 9, 2023 | Versant Venture Capital Vi, L.P. | 13D/A | 7.5% | 997.9K | SEC |
| 10 | Feb 14, 2023 | Rock Springs Capital Management LP | 13G/A | 7.8% | 823.7K | SEC |
10 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Tempest Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Versant Venture Management, LLC | 269.8K | $442.4K |